secwatch.observer — SEC 8-K summary
======================================

Issuer:     Relay Therapeutics, Inc. (RLAY)
CIK:        0001812364
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002682
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relay Therapeutics raises $30M in PIPE with Nextech; proceeds for RLY-2608 development
--------------------------------------------------------------------------------

- 2.5M shares sold at $12.00 each (premium to Jan 5 close); gross proceeds ~$30M.
- PIPE expected to close Jan 10, 2024; Nextech Crossover I SCP is the investor.
- Proceeds to advance RLY-2608 toward registrational trial(s) and preclinical pipeline.
- Company plans to disclose at least one new Dynamo platform program later in 2024.
- Resale registration statement to be filed within 15 business days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812364/000095017024002682/0000950170-24-002682-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812364/000095017024002682/rlay-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002682

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer